Jay J. Cho, Ph.D. is an Associate in the Firm’s Litigation department with a focus on patent litigation, particularly in the pharmaceutical and biotechnology space. Throughout his career, Jay has been involved in numerous patent cases related to, among other technologies, small molecules, polypeptides, vaccines, and antibodies in U.S. District Courts and before the Patent Trial and Appeal Board. Jay has litigated numerous patent cases brought under the Hatch-Waxman Act, and as a trial attorney, Jay had a major role in contributing to the recent victory for the innovator involving a blockbuster antipsychotic drug. With a deep knowledge in biochemistry, molecular biology and genetics, Jay has also represented pharmaceutical companies in various matters involving antibodies and antibody-related products.

  • U.S. Patent and Trademark Office
  • New York
  • Korean
  • Co-Author, "Drosophila Heparan Sulfate Proteoglycan Facilitation of Sema Mediated Repulsion During Axon Guidance," Genes Dev. (2012)